CompletedPhase 1NCT03371485

AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer

Studying Dendritic cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cancer Research UK
Principal Investigator
Gary Middleton, Prof
The Queen Elizabeth Hospital
Intervention
AST-VAC2(biological)
Enrollment
9 target
Eligibility
18 years · All sexes
Timeline
2018 – 2022

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03371485 on ClinicalTrials.gov

Other trials for Dendritic cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Dendritic cell tumor →

← Back to all trials